Related by context. Frequent words. (Click for all words.) 64 PREZISTA r 63 concomitant medications 62 renal dysfunction 61 renal insufficiency 60 hypokalemia 60 corticosteroid therapy 60 hypercalcemia 59 receiving VELCADE 59 hypomagnesemia 59 metabolic acidosis 59 thromboprophylaxis 58 nephrotoxicity 58 Coadministration 58 severe renal impairment 58 beta blocker therapy 58 refractory chronic lymphocytic 58 peginterferon alfa 57 hematologic toxicity 57 QTc interval 57 REVLIMID ® 57 discontinuations due 56 bone marrow suppression 56 immunosuppressive agents 56 tumor lysis syndrome 56 Lactic acidosis 56 renal impairment 56 hyperkalemia 56 intravenous immunoglobulin 56 antibiotic prophylaxis 56 thromboembolic events 56 hypoglycemic events 56 REVLIMID R 56 extrapyramidal symptoms 56 PRADAXA 56 oral corticosteroids 56 Fibrillex TM 56 hypocalcemia 56 antihypertensive medication 55 GEMZAR 55 diarrhea nausea vomiting 55 warfarin therapy 55 hepatic failure 55 carotid stenosis 55 azacitidine 55 deletion 5q cytogenetic abnormality 55 QTc prolongation 55 androgen deprivation 55 serum uric acid 55 voriconazole 55 angiotensin converting enzyme inhibitors 55 interferon therapy 54 thrombotic events 54 lamotrigine 54 Thrombocytopenia 54 ISTODAX 54 hyperbilirubinemia 54 laboratory abnormalities 54 leukopenia 54 coadministration 54 Exclusion criteria 54 prolactin levels 54 rhGH 54 ACTOplus met 54 platelet reactivity 54 docetaxel chemotherapy 54 methylprednisolone 54 COPD exacerbations 54 peripheral edema 53 tibolone 53 Secondary endpoints include 53 hypoxemia 53 NUCYNTA ® 53 uncontrolled hypertension 53 lactic acidosis 53 serum sodium 53 mg BID 53 PREZISTA 53 left ventricular dysfunction 53 thromboembolic 53 haemorrhagic stroke 53 lumiracoxib 53 systemic toxicity 53 thromboembolism 53 indinavir 53 fatal myocardial infarction 53 QT prolongation 53 CMV infection 53 myelosuppression 53 hypotension 53 elevated LDL cholesterol 53 Quetiapine 53 angioedema 53 lipid lowering drugs 52 renal toxicity 52 AVANDIA 52 intracerebral hemorrhage 52 Secondary endpoints 52 therapeutic regimens 52 coagulopathy 52 serum vitamin D 52 fibrinolysis